400 related articles for article (PubMed ID: 30518477)
1. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
Bushinsky DA
Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477
[TBL] [Abstract][Full Text] [Related]
2. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
3. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Acidosis of CKD: An Update.
Kraut JA; Madias NE
Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665
[TBL] [Abstract][Full Text] [Related]
5. NaHCO3 loading causes increased arterial pressure and kidney damage in rats with chronic kidney disease.
Mannon EC; Muller PR; Sun J; Bush WB; Coleman A; Ocasio H; Polichnowski AJ; Brands MW; O'Connor PM
Clin Sci (Lond); 2024 Feb; 138(4):189-203. PubMed ID: 38300615
[TBL] [Abstract][Full Text] [Related]
6. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
Di Iorio BR; Bellasi A; Raphael KL; Santoro D; Aucella F; Garofano L; Ceccarelli M; Di Lullo L; Capolongo G; Di Iorio M; Guastaferro P; Capasso G;
J Nephrol; 2019 Dec; 32(6):989-1001. PubMed ID: 31598912
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
Trials; 2013 Jul; 14():196. PubMed ID: 23826760
[TBL] [Abstract][Full Text] [Related]
8. Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease.
Goraya N; Simoni J; Sager LN; Mamun A; Madias NE; Wesson DE
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F502-F511. PubMed ID: 31215805
[TBL] [Abstract][Full Text] [Related]
9. Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease.
Goraya N; Wesson DE
Curr Opin Nephrol Hypertens; 2019 May; 28(3):267-277. PubMed ID: 30681417
[TBL] [Abstract][Full Text] [Related]
10. Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study.
Tyson CC; Luciano A; Modliszewski JL; Corcoran DL; Bain JR; Muehlbauer M; Ilkayeva O; Pourafshar S; Allen J; Bowman C; Gung J; Asplin JR; Pendergast J; Svetkey LP; Lin PH; Scialla JJ
Am J Kidney Dis; 2021 Jul; 78(1):38-47. PubMed ID: 33810868
[TBL] [Abstract][Full Text] [Related]
11. Acid retention in chronic kidney disease is inversely related to GFR.
Goraya N; Simoni J; Sager LN; Pruszynski J; Wesson DE
Am J Physiol Renal Physiol; 2018 May; 314(5):F985-F991. PubMed ID: 29357423
[TBL] [Abstract][Full Text] [Related]
12. Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate.
Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE
Am J Nephrol; 2019; 49(6):438-448. PubMed ID: 30995657
[TBL] [Abstract][Full Text] [Related]
13. [Metabolic acidosis in chronic kidney disease].
Havlín J; Matoušovic K; Vaňková S; Schück O
Vnitr Lek; 2016; 62 Suppl 6():30-39. PubMed ID: 28124929
[TBL] [Abstract][Full Text] [Related]
14. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.
Goraya N; Simoni J; Jo CH; Wesson DE
Clin J Am Soc Nephrol; 2013 Mar; 8(3):371-81. PubMed ID: 23393104
[TBL] [Abstract][Full Text] [Related]
15. Does correction of metabolic acidosis slow chronic kidney disease progression?
Goraya N; Wesson DE
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803
[TBL] [Abstract][Full Text] [Related]
16. Approach to the Treatment of Chronic Metabolic Acidosis in CKD.
Raphael KL
Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539
[TBL] [Abstract][Full Text] [Related]
17. Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection?
Mannon EC; O'Connor PM
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1090-F1104. PubMed ID: 33166183
[TBL] [Abstract][Full Text] [Related]
18. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
[TBL] [Abstract][Full Text] [Related]
19. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
[TBL] [Abstract][Full Text] [Related]
20. Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease.
Caravaca-Fontán F; Díaz-Campillejo R; Valladares J; López Arnaldo C; Barroso S; Luna E; Caravaca F
Nefrologia (Engl Ed); 2020; 40(3):328-335. PubMed ID: 31862183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
